The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: The EORTC QLQ-BM22

Abstract Aim The aim of this study was to develop a bone metastases module to supplement the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30) or the EORTC QLQ-C15-PAL for patients with bone metastases. Methods Phases 1–2 of module development were conduct...

Full description

Saved in:
Bibliographic Details
Published inEuropean Journal of Cancer Vol. 45; no. 7; pp. 1146 - 1152
Main Authors Chow, Edward, Hird, Amanda, Velikova, Galina, Johnson, Colin, Dewolf, Linda, Bezjak, Andrea, Wu, Jackson, Shafiq, Jesmin, Sezer, Orhan, Kardamakis, Dimitrios, Linden, Yvette van der, Ma, Brigette, Castro, Monica, Arnalot, Palmira Foro, Ahmedzai, Sam, Clemons, Mark, Hoskin, Peter, Yee, Albert, Brundage, Michael, Bottomley, Andrew
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.05.2009
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Aim The aim of this study was to develop a bone metastases module to supplement the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30) or the EORTC QLQ-C15-PAL for patients with bone metastases. Methods Phases 1–2 of module development were conducted in Canada, Australia and Germany according to EORTC QOL group guidelines. Phase 3 was conducted in nine countries in seven languages. Results Sixty-one health-related quality of life (HRQOL) issues were generated from health care professionals ( n = 152) and patients ( n = 413). This resulted in a 22-item provisional module. Further testing in 170 patients from nine countries resulted in the EORTC QLQ-BM22 module, containing 22 items, conceptualised into both symptom scales, with five painful sites and three pain characteristics, and also functional scales, with eight functional interference and six psychosocial aspects. Conclusion This study provides a provisional comprehensive HRQOL measurement tool for future trials, which will continue to undergo further validation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0959-8049
1879-0852
1359-6349
DOI:10.1016/j.ejca.2008.11.013